ARK Investment Management ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 11 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

ARK Investment Management ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2022$45,799
-28.7%
2,303,751
-3.4%
0.27%
+1.1%
Q1 2022$64,268
-29.8%
2,383,840
-3.6%
0.27%
-3.2%
Q4 2021$91,512
-24.3%
2,472,630
-2.2%
0.28%
-4.5%
Q3 2021$120,860
+23.8%
2,529,509
-12.3%
0.29%
+59.3%
Q2 2021$97,618
-29.1%
2,884,682
-13.4%
0.18%
-33.3%
Q1 2021$137,607
-19.9%
3,331,889
-15.8%
0.27%
-40.3%
Q4 2020$171,742
+60.4%
3,959,019
+58.6%
0.46%
-28.0%
Q3 2020$107,072
+19.4%
2,495,842
+30.1%
0.64%
-34.2%
Q2 2020$89,686
+321.8%
1,918,835
+22.7%
0.96%
+82.1%
Q1 2020$21,261
+41.4%
1,564,457
+13.1%
0.53%
+39.8%
Q4 2019$15,041
+14.9%
1,383,756
+8.6%
0.38%
+32.5%
Q3 2019$13,088
+38.0%
1,274,413
+26.9%
0.29%
+19.7%
Q2 2019$9,4811,004,3680.24%